Yes the outcome from Janssen study will be positive, if ProMarkerD can assess the effectiveness of Janssen's drug it means that it can also assess the effectiveness of competitor's drugs. This isn't exclusive. And then there's also the trial drugs. Huge opportunity.
PIQ may not be too far off from announcing the study results. This should be a big catalyst.
- Forums
- ASX - By Stock
- Ann: Proteomics International seeks FDA approval for PromarkerD
PIQ
proteomics international laboratories ltd
Add to My Watchlist
0.00%
!
39.5¢

Yes the outcome from Janssen study will be positive, if...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
39.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.65M |
Open | High | Low | Value | Volume |
39.0¢ | 40.0¢ | 38.0¢ | $98.01K | 252.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9722 | 38.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.5¢ | 44999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9722 | 0.380 |
1 | 1400 | 0.375 |
6 | 97160 | 0.370 |
1 | 10000 | 0.365 |
4 | 13174 | 0.360 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 44999 | 1 |
0.400 | 14573 | 2 |
0.410 | 100000 | 1 |
0.420 | 10000 | 1 |
0.430 | 20000 | 1 |
Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online